151 related articles for article (PubMed ID: 18070193)
21. Response rate as an endpoint in clinical trials.
George SL
J Natl Cancer Inst; 2007 Jan; 99(2):98-9. PubMed ID: 17227987
[No Abstract] [Full Text] [Related]
22. [Urologic Oncology Study Society. Promotor and facilitator of uro-oncologic clinical research].
Rexer H; Krege S
Urologe A; 2007 Sep; 46(9):1306-13. PubMed ID: 17701155
[No Abstract] [Full Text] [Related]
23. Comparison of outcomes of phase II studies and subsequent randomized control studies using identical chemotherapeutic regimens.
Zia MI; Siu LL; Pond GR; Chen EX
J Clin Oncol; 2005 Oct; 23(28):6982-91. PubMed ID: 16192585
[TBL] [Abstract][Full Text] [Related]
24. Clinical trials referral resource. Current clinical trials in rhabdomyosarcoma.
Anderson BD; Schoenfeldt M
Oncology (Williston Park); 2005 Sep; 19(10):1319-20, 1330. PubMed ID: 16285226
[No Abstract] [Full Text] [Related]
25. Epothilones and the next generation of phase III trials for prostate cancer.
Bhandari MS; Hussain M
BJU Int; 2005 Aug; 96(3):296-302. PubMed ID: 16042717
[No Abstract] [Full Text] [Related]
26. Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials.
Bria E; Gralla RJ; Raftopoulos H; Cuppone F; Milella M; Sperduti I; Carlini P; Terzoli E; Cognetti F; Giannarelli D
Lung Cancer; 2009 Jan; 63(1):50-7. PubMed ID: 18565615
[TBL] [Abstract][Full Text] [Related]
27. The ethics of early stopping rules.
Pater J; Goss P; Ingle J; Shelley W; Shepherd L
J Clin Oncol; 2005 Apr; 23(12):2862-3; author reply 2863-4. PubMed ID: 15838002
[No Abstract] [Full Text] [Related]
28. Comments on concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a mist of mysterious results.
Cheng SH; Huang AT
J Clin Oncol; 2005 Apr; 23(12):2864-5; author reply 2865-6. PubMed ID: 15838004
[No Abstract] [Full Text] [Related]
29. Randomized phase II trials: misleading and unreliable.
Stewart DJ
J Clin Oncol; 2010 Nov; 28(31):e649-50; author reply e651-3. PubMed ID: 20855829
[No Abstract] [Full Text] [Related]
30. Thalidomide in small cell lung cancer: wrong drug or wrong disease?
Rüegg C; Peters S
J Natl Cancer Inst; 2009 Aug; 101(15):1034-5. PubMed ID: 19608998
[No Abstract] [Full Text] [Related]
31. Neoadjuvant chemoradiotherapy in esophageal cancer: is it still the question?
Pereira B; Gourgou-Bourgade S; Azria D; Ychou M
J Clin Oncol; 2008 Nov; 26(31):5133-4; author reply 5134. PubMed ID: 18838699
[No Abstract] [Full Text] [Related]
32. Chemotherapy for prostate cancer in senior adults: are we treating the elderly or the frail?
Bellmunt J
Eur Urol; 2009 Jun; 55(6):1310-2. PubMed ID: 18778888
[No Abstract] [Full Text] [Related]
33. Preliminary results of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urothelium.
Yamada Y; Itoh Y; Aoki S; Nakamura K; Taki T; Naruse K; Tobiume M; Zennami K; Katsuda R; Kato Y; Watanabe M; Nishikawa G; Minami M; Nakahira M; Ukai S; Sawada M; Kitamura A; Honda N
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1079-83. PubMed ID: 19277660
[TBL] [Abstract][Full Text] [Related]
34. The role of cytoreductive nephrectomy in the era of molecular targeted therapy.
Polcari AJ; Gorbonos A; Milner JE; Flanigan RC
Int J Urol; 2009 Mar; 16(3):227-33. PubMed ID: 19207114
[TBL] [Abstract][Full Text] [Related]
35. Re: 'A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small-cell lung cancer: a randomized trial'.
Bregni M; Pedrazzoli P
J Natl Cancer Inst; 2009 Jan; 101(1):67; author reply 67-8. PubMed ID: 19116385
[No Abstract] [Full Text] [Related]
36. Progress in treatment of advanced urothelial tract tumors.
Yagoda A
J Clin Oncol; 1985 Nov; 3(11):1448-50. PubMed ID: 3903061
[No Abstract] [Full Text] [Related]
37. [Chemotherapy indications in the treatment of metastases from urological malignancies].
Théodore C
Prog Urol; 2008 Nov; 18 Suppl 7():S219-22. PubMed ID: 19070795
[TBL] [Abstract][Full Text] [Related]
38. The times they are a-changin' (Bob Dylan, 1964).
Bradley DA; Redman BG
Cancer; 2007 Dec; 110(11):2366-9. PubMed ID: 17941002
[No Abstract] [Full Text] [Related]
39. Maintenance therapy for ovarian cancer: of Helsinki and Hippocrates.
McGuire WP
J Clin Oncol; 2009 Oct; 27(28):4633-4. PubMed ID: 19704055
[No Abstract] [Full Text] [Related]
40. Diseases desperate grown.
Bunn PA
J Natl Cancer Inst; 2008 Apr; 100(8):520-1. PubMed ID: 18398099
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
